{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:03:11Z","timestamp":1780617791897,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06869-5","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:40:13Z","timestamp":1776832813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between 23S rRNA gene positivity and clinical characteristics in patients with mycoplasma pneumoniae pneumonia"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiayan","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoji","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"4","key":"6869_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","volume":"54","author":"TA Tsai","year":"2021","unstructured":"Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect. 2021;54(4):557\u201365.","journal-title":"J Microbiol Immunol Infect"},{"issue":"22","key":"6869_CR2","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.12998\/wjcc.v12.i22.4940","volume":"12","author":"LP Wang","year":"2024","unstructured":"Wang LP, Hu ZH, Jiang JS, Jin J. Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for mycoplasma severity. World J Clin Cases. 2024;12(22):4940\u20136.","journal-title":"World J Clin Cases"},{"issue":"7","key":"6869_CR3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.21037\/tp-24-245","volume":"13","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang J, Yang X, Wang T, Yan Y, Huang L, Xu J, Chen Z. Construction of a predictive model of respiratory endoscopic intervention in children with lobar pneumonia caused by Mycoplasma pneumoniae infection. Transl Pediatr. 2024;13(7):1219\u201330.","journal-title":"Transl Pediatr"},{"issue":"9","key":"6869_CR4","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/jac\/dkac170","volume":"77","author":"G Wang","year":"2022","unstructured":"Wang G, Wu P, Tang R, Zhang W. Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis. J Antimicrob Chemother. 2022;77(9):2353\u201363.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"6869_CR5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/jcm10061309","volume":"10","author":"HY Han","year":"2021","unstructured":"Han HY, Park KC, Yang EA, Lee KY. Macrolide-resistant and macrolide-sensitive mycoplasma pneumoniae pneumonia in children treated using early corticosteroids. J Clin Med. 2021;10(6):1309.","journal-title":"J Clin Med"},{"issue":"1","key":"6869_CR6","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Li M, Luo M, Luo Q, Kang L, Xie H, Wang Y, Yu X, Li A, Dong M, Huang F, Gong C. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg Microbes Infect. 2022;11(1):1508\u201317.","journal-title":"Emerg Microbes Infect"},{"issue":"7","key":"6869_CR7","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(7):e2220949.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6869_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12887-025-05819-x","volume":"25","author":"Y Luo","year":"2025","unstructured":"Luo Y, Wu R, Wu W, Zhao D, Jiang Y, Gu H. Differences in pulmonary microbiota of severe community-acquired pneumonia with different pathogenic microorganisms in children. BMC Pediatr. 2025;25(1):449.","journal-title":"BMC Pediatr"},{"issue":"6","key":"6869_CR9","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/ana.27193","volume":"97","author":"SE Olie","year":"2025","unstructured":"Olie SE, Staal SL, da Cruz Campos AC, Bodilsen J, Nielsen H, van de Beek D, Brouwer MC. Heparin-binding protein in cerebrospinal fluid as a biomarker for bacterial meningitis: a study of diagnostic accuracy. Ann Neurol. 2025;97(6):1088\u201395.","journal-title":"Ann Neurol"},{"key":"6869_CR10","doi-asserted-by":"publisher","first-page":"1438631","DOI":"10.3389\/fped.2024.1438631","volume":"12","author":"X Zhao","year":"2024","unstructured":"Zhao X, Lv J, Wu M, Wu Q. Clinical characteristics and risk factors for mycoplasma pneumoniae pneumonia in children. Front Pediatr. 2024;12:1438631.","journal-title":"Front Pediatr"},{"issue":"1","key":"6869_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s12879-025-11132-w","volume":"25","author":"T Ni","year":"2025","unstructured":"Ni T, Zhao F. Predicting myocardial damage in children with mycoplasma pneumoniae pneumonia: a retrospective case-control study. BMC Infect Dis. 2025;25(1):733.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"6869_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5409\/wjcp.v12.i3.115","volume":"12","author":"SO Yusuf","year":"2023","unstructured":"Yusuf SO, Chen P. Clinical characteristics of community-acquired pneumonia in children caused by mycoplasma pneumoniae with or without myocardial damage: A single-center retrospective study. World J Clin Pediatr. 2023;12(3):115\u201324.","journal-title":"World J Clin Pediatr"},{"issue":"6","key":"6869_CR13","first-page":"401","volume":"20","author":"S Yu","year":"2025","unstructured":"Yu S, Liu H, Liu E, Liu J, Song G, Chen Z, Zhang H, He Q, Zhao S, Duan F, Qian S, Gao H. Diagnosis and treatment guidelines for mycoplasma pneumoniae pneumonia in children (2025 Edition). Chin J Evid Based Pediatr. 2025;20(6):401\u20139. (In Chinese).","journal-title":"Chin J Evid Based Pediatr"},{"key":"6869_CR14","doi-asserted-by":"publisher","first-page":"1115009","DOI":"10.3389\/fped.2023.1115009","volume":"11","author":"M Leng","year":"2023","unstructured":"Leng M, Yang J, Zhou J. The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children. Front Pediatr. 2023;11:1115009.","journal-title":"Front Pediatr"},{"issue":"1","key":"6869_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/pathogens12010103","volume":"12","author":"IA Edelstein","year":"2023","unstructured":"Edelstein IA, Ivanova OV, Romashov OI, Kozlov RS. Course of lower respiratory tract infection in young people treated at the military hospital of smolensk garrison with detected mycoplasma pneumoniae carrying a macrolide-resistant mutation in 23S rRNA gene. Pathogens. 2023;12(1):103.","journal-title":"Pathogens"},{"issue":"9","key":"6869_CR16","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s10096-024-04902-y","volume":"43","author":"M Yan","year":"2024","unstructured":"Yan M, Tao R, Li S, Xiong J, Xiang J. Clinical characteristics and logistic regression analysis of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Eur J Clin Microbiol Infect Dis. 2024;43(9):1825\u201335.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"6869_CR17","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1038\/s41598-024-55311-2","volume":"14","author":"P Li","year":"2024","unstructured":"Li P, Wang W, Zhang X, Pan J, Gong L. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Sci Rep. 2024;14(1):5632.","journal-title":"Sci Rep"},{"issue":"1","key":"6869_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12879-024-09612-6","volume":"24","author":"M He","year":"2024","unstructured":"He M, Xie J, Rui P, Li X, Lai M, Xue H, Chen C. Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23S rRNA gene in pediatric patients. BMC Infect Dis. 2024;24(1):758.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6869_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12890-025-03704-y","volume":"25","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wen H, Liu Y, Xie H, Wu L, Fu Z, Sicheng C, Zhang D. Correlation analysis between clinical characteristics of adult patients with Mycoplasma pneumoniae pneumonia and 23S rRNA A2063 gene in alveolar lavage fluid. BMC Pulm Med. 2025;25(1):319.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"6869_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0300060517716312","volume":"46","author":"H Deng","year":"2018","unstructured":"Deng H, Rui J, Zhao D, Liu F. Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia. J Int Med Res. 2018;46(1):150\u20137.","journal-title":"J Int Med Res"},{"issue":"11","key":"6869_CR21","first-page":"1176","volume":"26","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang Y, Cai LJ. [Analysis of multidrug resistance gene locus mutations and clinical significance in children with Mycoplasma pneumoniae pneumonia]. Zhongguo Dang Dai Er Ke Za Zhi. 2024;26(11):1176\u201381.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"1","key":"6869_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1186\/s12879-025-11584-0","volume":"25","author":"R Shen","year":"2025","unstructured":"Shen R, Zhou L, Chen Y, Chen Y, Yang S. Clinical characteristics of mycoplasma pneumoniae pneumonia in children with 23S rRNA mutations in domain V and exploration of the timing of glucocorticoid therapy. BMC Infect Dis. 2025;25(1):1148.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6869_CR23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12879-022-07456-6","volume":"22","author":"S Choo","year":"2022","unstructured":"Choo S, Kim SH, Lee E. Clinical significance of Mycoplasma pneumoniae specific IgM titer in children hospitalized with Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2022;22(1):470.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6869_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00284-022-03103-0","volume":"80","author":"J Hu","year":"2022","unstructured":"Hu J, Ye Y, Chen X, Xiong L, Xie W, Liu P. Insight into the pathogenic mechanism of mycoplasma pneumoniae. Curr Microbiol. 2022;80(1):14.","journal-title":"Curr Microbiol"},{"key":"6869_CR25","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.ijmmb.2023.100480","volume":"46","author":"S Kumar","year":"2023","unstructured":"Kumar S, Kumar S. Mycoplasma pneumoniae: Among the smallest bacterial pathogens with great clinical significance in children. Indian J Med Microbiol. 2023;46:100480.","journal-title":"Indian J Med Microbiol"},{"issue":"4","key":"6869_CR26","doi-asserted-by":"publisher","first-page":"e0461322","DOI":"10.1128\/spectrum.04613-22","volume":"11","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Dou H, Yuan Q, Shi D, Wan R, Tu P, Xin D, Guo S. Proteomic and phenotypic studies of mycoplasma pneumoniae revealed macrolide-resistant mutation (A2063G) associated changes in protein composition and pathogenicity of type I strains. Microbiol Spectr. 2023;11(4):e0461322.","journal-title":"Microbiol Spectr"},{"issue":"5","key":"6869_CR27","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1002\/iid3.849","volume":"11","author":"F Deng","year":"2023","unstructured":"Deng F, Cao H, Liang X, Li Q, Yang Y, Zhao Z, Tan J, Fu G, Shu C. Analysis of cytokine levels, cytological findings, and MP-DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia. Immun Inflamm Dis. 2023;11(5):e849.","journal-title":"Immun Inflamm Dis"},{"issue":"6","key":"6869_CR28","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1096\/fj.08-121277","volume":"23","author":"A Di Gennaro","year":"2009","unstructured":"Di Gennaro A, Kenne E, Wan M, Soehnlein O, Lindbom L, Haeggstrom JZ. Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP\/CAP37\/azurocidin). FASEB J. 2009;23(6):1750\u20137.","journal-title":"FASEB J"},{"issue":"8","key":"6869_CR29","first-page":"629","volume":"20","author":"Y Chen","year":"2018","unstructured":"Chen Y, Tian WM, Chen Q, Zhao HY, Huang P, Lin ZQ, Chen L. [Clinical features and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children]. Zhongguo Dang Dai Er Ke Za Zhi. 2018;20(8):629\u201334.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"6869_CR30","doi-asserted-by":"crossref","unstructured":"Shirasaki K, Minai K, Ogawa K, Nagoshi T, Ogawa T, Kawai M, Tokuda M, Yoshimura M. Association of neutrophil-to-lymphocyte ratio (NLR) with the infarct size in acute myocardial infarction (AMI), through peak creatine kinase (CK) and peak creatine kinase-myocardial band (CK-MB): A retrospective observational study. Medicine (Baltimore). 2025;104(51):e46725.","DOI":"10.1097\/MD.0000000000046725"},{"issue":"7","key":"6869_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/1348-0421.12267","volume":"59","author":"Q Fan","year":"2015","unstructured":"Fan Q, Meng J, Li P, Liu Z, Sun Y, Yan P. Pathogenesis and association of Mycoplasma pneumoniae infection with cardiac and hepatic damage. Microbiol Immunol. 2015;59(7):375\u201380.","journal-title":"Microbiol Immunol"},{"key":"6869_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/JIR.S393600","volume":"16","author":"S Li","year":"2023","unstructured":"Li S, Xu Y, Wu Y, Huang H, Sun C, Xu S, Li H, Zhang X, Zhao S, Huang L. Heparin-Binding protein: a prognostic biomarker associated with severe or complicated community-acquired pneumonia in children. J Inflamm Res. 2023;16:321\u201331.","journal-title":"J Inflamm Res"},{"key":"6869_CR33","doi-asserted-by":"publisher","first-page":"759535","DOI":"10.3389\/fped.2021.759535","volume":"9","author":"C Huang","year":"2021","unstructured":"Huang C, Zhang C, Zhang J, Zhang L, Mo Y, Mo L. Heparin-Binding Protein in Critically Ill children with severe community-acquired pneumonia. Front Pediatr. 2021;9:759535.","journal-title":"Front Pediatr"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06869-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06869-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06869-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:20:18Z","timestamp":1780615218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06869-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6869"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06869-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Anhui Provincial Children\u2019s Hospital (Approval No. EYLL-2025-056) and was conducted in accordance with the Declaration of Helsinki. Given the retrospective nature of the study and the use of anonymized clinical data, the requirement for written informed consent was waived by the Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"527"}}